Nature Communications (Jun 2022)
Ligand recognition and biased agonism of the D1 dopamine receptor
Abstract
D1 dopamine receptor is an important drug target for treatment of hypertension and Parkinson’s disease. Here, authors report three cryo-EM structures of the D1R-Gs complex bound to three distinct D1R-selective drugs.